Blood cancer Clinical Trials in Milwaukee, WI
As of August 2026, 60 paid clinical trials are recruiting for Blood cancer in Milwaukee, Wisconsin. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Milwaukee
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
61 clinical trials for Blood cancer
·Clear filters·A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Study of SGR-1505 in Mature B-Cell Neoplasms
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
A Study of BGB-11417 in Participants With Myeloid Malignancies
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Top Research Study Locations in Milwaukee
Researchers run research studies in Milwaukee, WI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Medical College of Wisconsin | Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Stroke | 248 |
| Aurora Sinai Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 50 |
| Aurora Saint Luke's Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 48 |
| Aurora Cancer Care-Milwaukee | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 46 |
| Children's Hospital of Wisconsin | B Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Malignant Solid Neoplasm | 42 |
| Froedtert & the Medical College of Wisconsin | Multiple Myeloma, Pancreatic Cancer, Refractory Multiple Myeloma | 23 |
| Children's Wisconsin | Abdominal Pain, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Refractory | 20 |
| Froedtert Hospital and the Medical College of Wisconsin | Central Nervous System Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL), Refractory Diffuse Large B Cell Lymphoma (DLBCL) | 19 |
| Froedtert Hospital & the Medical College of Wisconsin | Breast Cancer, Pancreas Cancer, Acute Myeloid Leukemia (AML) | 18 |
| Aurora St. Luke's Medical Center | Pulmonary Hypertension, Acute Decompensated Heart Failure, Acute Ischemic Stroke From Large Vessel Occlusion | 15 |
| Froedtert Hospital | Aortic Stenosis, Bladder Cancer, Breast Cancer | 15 |
| The Medical College of Wisconsin | Abdominal Wound Dehiscence, Acute Kidney Injury, Anal Fistula | 12 |
| Ascension Columbia Saint Mary's Hospital-Milwaukee Campus | Ampulla of Vater Carcinoma, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Froedtert & Medical College of Wisconsin | Cystic Fibrosis (CF), AML, Acute Myeloid Leukemia | 10 |
| Marquette University | Aging, Stroke, Aerobic Exercise | 8 |
| Zablocki Veterans Administration Medical Center | Stage IVA Prostate Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 7 |
| Froedtert and The Medical College of Wisconsin | Advanced Renal Cell Carcinoma (aRCC), Aggressive Variant Prostate Carcinoma, Clear Cell Renal Cell Carcinoma (ccRCC) | 6 |
| Ascension Columbia Saint Mary's Hospital - Milwaukee | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma | 5 |
| Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile | 5 |
| Ascension Saint Francis Hospital-Milwaukee | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile | 4 |
| Aurora St Luke's Medical Center | AMI, Cancer, Cutaneous Melanoma, Stage II | 4 |
| Clement J. Zablocki VA Medical Center, Milwaukee, WI | Atherosclerosis, De Novo Prostate Cancer, Lung Neoplasm | 4 |
| Medical College of Wisconsin/Children's Hospital of Wisconsin | Primary Immune Deficiency Disorder, Adenovirus, Covid19 | 4 |
| Advocate Aurora Research Institute | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 3 |
| Ascension Saint Francis Hospital | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 3 |
Active & Upcoming Studies in Milwaukee (2026)
Recruiting trials in Milwaukee grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (268 active studies)
- FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma · Phase 1 · Medical College of Wisconsin
- Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer · Phase 2 · Medical College of Wisconsin
Cardiovascular (49 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Peripheral Venous Pressure (PVP) Trial · Wake Forest University Health Sciences
Neurology & pain (34 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
Diabetes & metabolic (20 active studies)
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study · Medical College of Wisconsin
- Puerto Rican Obesity Intervention for Men · Medical College of Wisconsin
Pediatric (11 active studies)
- Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers · Medical College of Wisconsin
- Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure · Medical College of Wisconsin
Mental health & behavior (5 active studies)
- My Path to Quit Tobacco · Phase 4 · University of Wisconsin, Madison
- Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers · Marquette University
HIV / STI (3 active studies)
- Screen Smart: Using Digital Health to Improve HIV Screening and Prevention · Children's Hospital Medical Center, Cincinnati
- Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV · Medical College of Wisconsin
Vaccines (1 active study)
Eye & vision (1 active study)
- Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease · Phase 2 · Alkeus Pharmaceuticals, Inc.
Common conditions studied in Milwaukee
- Acute Myeloid Leukemia (14 active studies)
- Breast Cancer (13 active studies)
- Heart Failure (13 active studies)
- Multiple Myeloma (11 active studies)
- Chronic Lymphocytic Leukemia (10 active studies)
- Follicular Lymphoma (10 active studies)
Leading research sponsors in Milwaukee
- Medical College of Wisconsin
- National Cancer Institute (NCI)
- AstraZeneca
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Milwaukee?
There are approximately 666 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milwaukee pay participants?
Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milwaukee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milwaukee?
The most common conditions under active study in Milwaukee include Acute Myeloid Leukemia (14), Breast Cancer (13), Heart Failure (13), Multiple Myeloma (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milwaukee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milwaukee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milwaukee?
Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milwaukee right now?
The largest active categories in Milwaukee are Cancer & tumors (268), Cardiovascular (49), Neurology & pain (34). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.